Hearing loss attributed to desferrioxamine in patients with beta-thalassaemia major.
Schindléry
C
C
D003676:Deferoxamine / Q000009:adverse effects*; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced*; D006801:Humans; D013789:Thalassemia / Q000188:drug therapy*
D003676:Deferoxamine